Trending...
- Spokane: US 195 Project To Improve Traffic Safety
- 5 Practical Ways to Increase Nitric Oxide Naturally
- JEGS Launches Modern, Secure Payments Powered by PhaseZero.ai
SEATTLE, May 14, 2021 /PRNewswire/ -- Case No 16-2-29568-1 SEA involved a handyman living a very peaceful, simple life. He was not wealthy by any means, but he loved his work and life was good. That was until one day while waiting at a stoplight, a vehicle struck him from behind at approximately 45 MPH, changing his life forever. His new normal included not being able to work, $70,000 in medical bills, struggling daily with chronic pain, the mental anguish of no one believing him, and learning the hard way just how poor his insurance coverage was. To further exacerbate his predicament, his injuries and pain were not corroborated with X-Rays, MRI's, CT Scans or Range of Motion.
His doctor, frustrated with the lack of findings, did some research and discovered MyoVision's DynaROM Motion EMG (a diagnostic tool that can prove the presence or absence of soft tissue injury) was being used by South Korean Orthopedic Surgeons to document soft tissue injury. The DynaROM was also published in the AMA's guidebook "A Practical Guide to Range of Motion Assessment," with the author referring to it as the "new gold standard" as it was more sensitive to soft tissue injury than ROM alone. The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body's natural response to pain). So the handyman's doctor ordered a DynaROM test and what happened next made history. The jury awarded $958K; one of the largest soft tissue injury awards in history.
More on Washingtoner
The handyman described the DynaROM as, "The missing puzzle piece that validated my pain. The jury understood the simple graphics that proved the insurance defense wrong. The DynaROM was essential to obtaining the award, and I am forever grateful that it has allowed me to continue care and the work I love, but at a pace which does not leave me in constant pain."
About the MyoVision SERIES-5 DynaROM
Developed under a prestigious NIH Grant, the new SERIES-5 is the result of thousands of hours of R&D and clinical application in the healthcare arena. MyoVision has been manufacturing medical equipment in the US for the past 30 years. For more information, visit myovision.com or email [email protected]
SOURCE MyoVision
Related Links
https://www.myovision.com/
His doctor, frustrated with the lack of findings, did some research and discovered MyoVision's DynaROM Motion EMG (a diagnostic tool that can prove the presence or absence of soft tissue injury) was being used by South Korean Orthopedic Surgeons to document soft tissue injury. The DynaROM was also published in the AMA's guidebook "A Practical Guide to Range of Motion Assessment," with the author referring to it as the "new gold standard" as it was more sensitive to soft tissue injury than ROM alone. The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body's natural response to pain). So the handyman's doctor ordered a DynaROM test and what happened next made history. The jury awarded $958K; one of the largest soft tissue injury awards in history.
More on Washingtoner
- Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
- The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
- Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
- Spokane: Shooting on Wellesley Leaves One Person Deceased and Another Injured
- Spokane: District 3 Council Members to Host Community Town Hall
The handyman described the DynaROM as, "The missing puzzle piece that validated my pain. The jury understood the simple graphics that proved the insurance defense wrong. The DynaROM was essential to obtaining the award, and I am forever grateful that it has allowed me to continue care and the work I love, but at a pace which does not leave me in constant pain."
About the MyoVision SERIES-5 DynaROM
Developed under a prestigious NIH Grant, the new SERIES-5 is the result of thousands of hours of R&D and clinical application in the healthcare arena. MyoVision has been manufacturing medical equipment in the US for the past 30 years. For more information, visit myovision.com or email [email protected]
SOURCE MyoVision
Related Links
https://www.myovision.com/
0 Comments
Latest on Washingtoner
- Animal Communicator Vicki Draper Helps Pet Parents Reduce Stress and Improve Behavior Naturally
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
- "FRAUD: Federal Reliance, Regulatory Blindness, ANAB Misrepresentation, Unchecked Conflicts, And Deception -The Guberman Definition
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
- EFA Announces 2026 Editorial Rate Chart
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- City of Spokane And City Council Announce 2026 Washington State Legislative Outcomes
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- Tacoma: Applications Sought for the City's Events and Recognitions Committee
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry